SCHEMBL7419141

SCHEMBL7419141

N#CC1(N(Cc2ccccc2)C(=O)C(CNC(=O)c2ccc(Cl)cc2)C2CCCCC2)CCNC1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AGER Q15109 1/20 0.39
CXCR3 P49682 3/20 0.38
SLC6A9 P48067 2/20 0.37
SLC6A5 Q9Y345 2/20 0.37
CYP2D6 P10635 1/20 0.37
CYP2C9 P11712 1/20 0.37
TMEM97 Q5BJF2 4/20 0.37
SIGMAR1 Q99720 4/20 0.37
PRMT5 O14744 3/20 0.35
LMNA P02545 1/20 0.35
MAPT P10636 1/20 0.35
HTT P42858 1/20 0.35
NPSR1 Q6W5P4 1/20 0.35
PSEN1 P49768 1/20 0.34
PSEN2 P49810 1/20 0.34
APH1B Q8WW43 1/20 0.34
NCSTN Q92542 1/20 0.34
APH1A Q96BI3 1/20 0.34
PSENEN Q9NZ42 1/20 0.34
GCGR P47871 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7014342 0.88 CTSS (0.41) PRMT5
SCHEMBL7422438 0.86 PKM (0.42) SIGMAR1LMNA
SCHEMBL7417235 0.85 L3MBTL1 (0.35) CYP2D6LMNAHTTNPSR1
SCHEMBL7414878 0.84 BACE1 (0.41) CYP2C9TMEM97SIGMAR1PRMT5LMNA
SCHEMBL7419135 0.83 CTSS (0.45) AGER
SCHEMBL7413191 0.82 CTSS (0.37) TMEM97SIGMAR1LMNAHTTNPSR1
SCHEMBL7413188 0.79 CTSS (0.39) LMNAHTTNPSR1
SCHEMBL6371524 0.78 L3MBTL1 (0.40) HTTNPSR1
SCHEMBL7415546 0.75 PSEN1 (0.34) AGERSLC6A9SLC6A5CYP2D6CYP2C9
SCHEMBL7420833 0.72 L3MBTL1 (0.41) HTTNPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1218372-A1 NOVEL SPIROHETEROCYCLIC COMPOUNDS USEFUL AS REVERSIBLE INHIBITORS OF CYSTEINE PROTEASES Boehringer Ingelheim Pharmaceuticals, Inc. (US) 2002-07-03 EP disclosed
WO-2001019816-A1 NOVEL SPIROHETEROCYCLIC COMPOUNDS USEFUL AS REVERSIBLE INHIBITORS OF CYSTEINE PROTEASES BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. (US) 2001-03-22 WO disclosed